beta-N-acetyl-D-glucosaminidase isoenzymes by chromatofocusing from serum and skin in diabetes.

[1]  A. Orlacchio,et al.  Serum ß-N-Acetylglucosaminidase Activity in Diabetic Patients during Conventional Therapy and during Treatment by Artificial Systems for Insulin Delivery , 1984 .

[2]  A. Orlacchio,et al.  The effect of membrane phospholipid acyl-chain composition on the activity of brain-beta-N-acetyl-D-glucosaminidase. , 1981, The Biochemical journal.

[3]  J. Cabezas,et al.  Increased serum α-l-fucosidase and β-N-acetylglucosaminidase activities in diabetic, cirrhotic and gastric cancer patients , 1980 .

[4]  L. Borthwick,et al.  Serum and urine N-acetyl-beta-D-glucosaminidase in diabetics on diagnosis and subsequent treatment, and stable insulin dependent diabetics. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[5]  Tarui Seiichiro,et al.  Retina, tear and serum β-N-acetylglucosaminidase activities in diabetic patients , 1976 .

[6]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[7]  S. Tarui,et al.  Beta-glycosidases and diabetic microangiopathy. I. Decreases of beta-glycosidase activities in diabetic rat kidney. , 1976, Journal of biochemistry.

[8]  J. Verpoorte.  Isolation and characterization of the major beta-N-acetyl-D-glucosaminidase from human plasma. , 1974, Biochemistry.

[9]  R. G. Price,et al.  The demonstration of multiple heat stable forms of N-acetyl- -glucosaminidase in normal human serum. , 1972, Biochimica et biophysica acta.